Terence R. Flotte, MD
Celia and Isaac Haidak Professor, Dean of the T.H. Chan School of Medicine
Provost and Executive Deputy Chancellor
About the deanTerence R. Flotte, MD, is provost, dean and executive deputy chancellor of UMass Chan Medical School, the only public medical school in Massachusetts. Since joining UMass Chan in 2007, Dr. Flotte has forged a path of unprecedented growth and achievement for the research, education and academic missions of the campus. An internationally known scientist, Flotte has conducted research on cutting edge molecular therapeutics that led to the first successful gene transfer with adeno-associated virus (AAV) in animals and the first ever human trial of an AAV. He also led the first human recombinant AAV trials in alpha-1 antitrypsin deficiency and Tay-Sachs disease, with the latter showing promising clinical benefits. He is the author of more than 280 scholarly papers and his research has been funded by the National Institutes of Health and the Alpha One Foundation. Since 2015, Flotte has also been editor-in-chief of gene therapy’s oldest journal family, Human Gene Therapy. |
-
Jun 5, 2022Read more
-
Jun 3, 2022
Resilient T.H. Chan School of Medicine Class of 2022 honored at awards ceremony
Read more -
Jun 2, 2022
UMass Chan Gold Humanism Honor Society chapter inducts 36
Read more -
May 24, 2022
Women’s Faculty Awards spotlight excellence at UMass Chan Medical School
Read more -
May 20, 2022
UMass Chan research explores differences in AAV vector manufacture, shows clear winner for method
Read more -
May 13, 2022
Student-created mentorship groups shine through UMass LIGHT
Read more -
Apr 27, 2022
Educational Recognition Awards and Last Lecture celebrate faculty excellence at UMass Chan
Read more -
Mar 29, 2022
UMass Chan Medical School ranks 10th nationwide for primary care education
Read more -
Mar 4, 2022
Mass. Life Sciences Center grant to support infrastructure for tracking, imaging viruses at UMass Chan
Read more -
Feb 10, 2022
Raiden Science Foundation makes gift to UMass Chan for UBA5 gene therapy research
Read more